Immunisation of mares with binding domains of toxins A and B ofClostridium difficileelicits serum and colostral antibodies that block toxin binding

Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine

(2012) Richard N. Greenberg et al.   VACCINE

Development and Evaluation of an Ovine Antibody-Based Platform for Treatment of Clostridium difficile Infection

(2011) April Roberts et al.   INFECTION AND IMMUNITY

Serum antibody responses in horses and mice following immunization with Actinobacillus equuli outer membrane proteins and recombinant Aqx toxin

(2011) Jeffery S. Skaggs et al.   VETERINARY JOURNAL

Prevalence of Clostridium difficile in horses

(2011) Carlos E. Medina-Torres et al.   VETERINARY MICROBIOLOGY

Clostridium difficile infection: epidemiology, risk factors and management

(2010) Ashwin N. Ananthakrishnan   Nature Reviews Gastroenterology & Hepatology

A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A

(2009) David F. Gardiner et al.   VACCINE

Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A

(2008) Claribel P. Taylor et al.   VACCINE

Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility

(2007) V. BÅVERUD et al.   EQUINE VETERINARY JOURNAL